(2023)
Semi-quantitative FDG parameters predict survival in multiple myeloma patients without autologous stem cell transplantation.
CANCER IMAGING.
23,
1
(2023)
Outcome of Multiple Myeloma Patients With Hepatitis Surface Antigen: Korean Multiple Myeloma Working Party 2103 Study.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA.
S2152-2650,
23
(2023)
Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup Analysis.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA.
23,
10
(2023)
Direct comparison of diagnostic and clinical values between Tc-99 m DPD and Tc-99 m PYP scintigraphy in patients with cardiac amyloidosis.
BMC MEDICAL IMAGING.
23,
1
(2023)
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015).
ANNALS OF HEMATOLOGY.
102,
8
(2023)
Cluster analysis of autoencoder-extracted FDG PET/CT features identifies multiple myeloma patients with poor prognosis.
SCIENTIFIC REPORTS.
13,
1
(2023)
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.
BLOOD CANCER JOURNAL.
13,
1
(2023)
A comprehensive overview of AL amyloidosis disease characteristics accumulated over two decades at a single referral center in Korea.
INTERNATIONAL JOURNAL OF HEMATOLOGY.
117,
5
(2023)
Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma.
INTERNATIONAL JOURNAL OF HEMATOLOGY.
117,
2
(2023)
Single Center Experience of Autologous Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis in Korea.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA.
23,
2
(2022)
Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease.
JOURNAL OF HEMATOLOGY & ONCOLOGY.
15,
1
(2022)
Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysis.
INTERNATIONAL JOURNAL OF HEMATOLOGY.
116,
4
(2022)
Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma.
ANNALS OF LABORATORY MEDICINE.
42,
5
(2022)
Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study).
FRONTIERS IN ONCOLOGY.
12,
(2022)
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA.
22,
8
(2022)
Characteristics and clinical outcome of high-risk multiple myeloma patients in Korea (KMM 1805).
INTERNATIONAL JOURNAL OF HEMATOLOGY.
116,
1
(2022)
Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma.
ANNALS OF HEMATOLOGY.
101,
6
(2022)
Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma.
BLOOD ADVANCES.
-,
-
(2022)
Prognostic Implication of Longitudinal Changes of Left Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis.
FRONTIERS IN CARDIOVASCULAR MEDICINE.
9,
(2021)
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and F-18-FDG PET/CT.
BLOOD CANCER JOURNAL.
11,
12
학술회의논문
(2009)
Decitabine Activity in Myelodysplastic Syndromes International Coopera-tive Multi Center Study.
BLOOD.
미국
(2009)
Effectiveness of Decitabine Chronic Myelomonocytic
Leukemia Patients International Cooperative Nulti-Center Study114.
BLOOD.
미국
(2009)
Monosomy Karyotype in Acute Myeloid Leukemia Predicts Adverse Treatment Outcome with Low Complete Remission Rate and Worse Event-Free
and Overall Survival and Associates with High Functional Acivity of Multidrung Resistance..
BLOOD.
미국
(2009)
candidate Pathway Approach of Singe Nucleotide polymorphism On Imatininab Transport/Metabolism Pathway and DNA Repair Enzyme Pathway
Associated with Response and Resistanse to Imatinib Therapy in Chronic Myeloid Leukemia.
BLOOD.
미국
(2009)
comprehensive Evaluation of Time-To-Response Parameter as a Predictor of Long-Term Outcomes Following Imatinib Therapy in Chronic Phase Chronic Myeloid Leukemia.
BLOOD.
미국
(2009)
Immunoglobulin D multiple myeloma: Clinical presentation, response to therapy and prognostic factors in 77 patients.
제50차 대한혈액학회 춘계학술대회.
대한민국
(2009)
Non-Hodgkin lymphoma of rare extranodal sites: Are they different from commonly involved sites?.
제50차 대한혈액학회 춘계학술대회.
대한민국
(2006)
Immunotherapy with autologous tumor lysates-pulsed dentritic cells for patients with metastatic renal cell carcinoma..
Annals of Oncology.
튀르키예
(2005)
somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma..
Journal of Clinical Oncology..
미국
(2004)
Clinical significance of insulin-like growth factor-binding protein-3 expression in advanced gastric cancer.
European journal of cancer:EORTC-NCI-AACR Conference on Molecular targets and cancer therapeutics.
스위스
(2004)
Clinical significance of insulin-like growth factor-binding protein-3 expression in advanced gastric cancer.
European journal of cancer:EORTC-NCI-AACR Conference on Molecular targets and cancer therapeutics.
스위스
(2004)
A Phase II Trial of Irinotecan, Leucovorin and 5FU Combination Chemotherapy for Metastatic AGC.
Cancer Research and Treatment.
대한민국
(2004)
Adjuvant Chemotherapy with 5-FU/Cisplatin in Patients with Regional LN (+) Thoracic Esophageal SCC.
Cancer Research and Treatment.
대한민국
(2004)
Paclitaxel and Platinum Combination in Anthra-cycline-Pretreated Metastatic Breast Cancer.
Cancer Research And Treatment.
대한민국
(2004)
Dose-intensive CHOP chemotherapy followed by radiation for localized NK/T cell lymphoma.
Journal of Clinical Oncology.
미국
(2003)
A Phase II Study of combination chemotherapy with paclitaxel and platinum in anthracycline - pretreated metastatic breast cancer.
대한암학회지.
대한민국
(2003)
Doxorubicin plus Docetaxel as Neoadjuvant Treatment in Patients with Locally Advanced Cracinoma of the Breast.
대한내과학회지.
대한민국
(2003)
A Phase II study of combination chemotherapy with docetaxel, epirubicin, and cisplatin in inoperable gastric Cancer: Preliminary data..
American Society of Clinical Oncology.
미국
(2003)
A Phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancer..
American Society of Clinical Oncology.
미국
(2003)
Phase II trial of weekly 24-hour infusion of gemcitabine with concurrent radiation therapy for the treatment of locally advanced pancreatic cancer..
American Society of Clinical Oncology.
미국
